To elucidate regulatory principles of pathway-triggered gene transcription, we firstly identified common clusters of target genes sensitive to MEK inhibition in three colorectal cancer cell lines carrying KRAS or BRAF mutations. The gene discussed is BRAF; the disease is colorectal cancer.